-
Signature
-
/s/ Julie Dimmick, as attorney-in-fact
-
Stock symbol
-
LASR
-
Transactions as of
-
Oct 8, 2024
-
Transactions value $
-
-$311,400
-
Form type
-
4
-
Date filed
-
10/10/2024, 09:01 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
LASR |
Common Stock |
Options Exercise |
$11.3K |
+15K |
+1.11% |
$0.75 |
1.36M |
Oct 8, 2024 |
Direct |
F1 |
transaction |
LASR |
Common Stock |
Sale |
-$167K |
-15K |
-1.1% |
$11.15 |
1.35M |
Oct 8, 2024 |
Direct |
F1, F2, F3 |
transaction |
LASR |
Common Stock |
Options Exercise |
$11.3K |
+15K |
+1.11% |
$0.75 |
1.36M |
Oct 9, 2024 |
Direct |
F1 |
transaction |
LASR |
Common Stock |
Sale |
-$167K |
-15K |
-1.1% |
$11.11 |
1.35M |
Oct 9, 2024 |
Direct |
F1, F2, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
LASR |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
0 |
0% |
$0.00 |
1K |
Oct 8, 2024 |
Common Stock |
15K |
$0.75 |
Direct |
F5 |
transaction |
LASR |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
0 |
|
$0.00 |
0 |
Oct 9, 2024 |
Common Stock |
1K |
$0.75 |
Direct |
F5 |
transaction |
LASR |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
0 |
0% |
$0.00 |
144K |
Oct 9, 2024 |
Common Stock |
14K |
$0.75 |
Direct |
F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: